# Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel

> **NCT01202799** · PHASE1 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 30 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** 2% w/w diclofenac sodium topical gel
- **DRUG:** 1.5% w/w diclofenac sodium topical solution
- **DRUG:** 75 mg diclofenac sodium delayed release tablet

## Key facts

- **NCT ID:** NCT01202799
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202799, "Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01202799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*